BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18708356)

  • 1. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification.
    Zhu J; Zhu S; Guzzo CM; Ellis NA; Sung KS; Choi CY; Matunis MJ
    J Biol Chem; 2008 Oct; 283(43):29405-15. PubMed ID: 18708356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
    Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
    Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis.
    Zhang XD; Goeres J; Zhang H; Yen TJ; Porter AC; Matunis MJ
    Mol Cell; 2008 Mar; 29(6):729-41. PubMed ID: 18374647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1.
    Kawabe Y; Seki M; Seki T; Wang WS; Imamura O; Furuichi Y; Saitoh H; Enomoto T
    J Biol Chem; 2000 Jul; 275(28):20963-6. PubMed ID: 10806190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.
    Matic I; van Hagen M; Schimmel J; Macek B; Ogg SC; Tatham MH; Hay RT; Lamond AI; Mann M; Vertegaal ACO
    Mol Cell Proteomics; 2008 Jan; 7(1):132-44. PubMed ID: 17938407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
    Sampson DA; Wang M; Matunis MJ
    J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
    Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
    Cuijpers SAG; Willemstein E; Vertegaal ACO
    Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
    Desterro JM; Rodriguez MS; Kemp GD; Hay RT
    J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small ubiquitin-related modifiers in chains.
    Vertegaal AC
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish.
    Yuan H; Zhou J; Deng M; Liu X; Le Bras M; de The H; Chen SJ; Chen Z; Liu TX; Zhu J
    Cell Res; 2010 Feb; 20(2):185-96. PubMed ID: 19704416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
    Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
    Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.
    Su HL; Li SS
    Gene; 2002 Aug; 296(1-2):65-73. PubMed ID: 12383504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.